Investigations into NSCLC tissues have shown that NCL is more abundantly expressed in cancerous tissues than in healthy counterparts, particularly from early stages, with the proportion of NCL‐positive cells increasing significantly as the cancer progresses. The gene discussed is NUCLEOLIN; the disease is cancer.